Interleukin-6 Is an Autocrine Growth Factor in Human Prostate Cancer
Top Cited Papers
- 1 December 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (6), 2159-2165
- https://doi.org/10.1016/s0002-9440(10)63067-2
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Veterans Affairs (R01 DK54170)
- National Institutes of Health (R01 DK54170)
This publication has 27 references indexed in Scilit:
- Increased Expression of the Interleukin-11 Receptor and Evidence of STAT3 Activation in Prostate CarcinomaThe American Journal of Pathology, 2001
- CYTOKINE VARIATIONS IN PATIENTS WITH HORMONE TREATED PROSTATE CANCERJournal of Urology, 2000
- CYTOKINE VARIATIONS IN PATIENTS WITH HORMONE TREATED PROSTATE CANCERJournal of Urology, 2000
- FGF7 AND FGF2 ARE INCREASED IN BENIGN PROSTATIC HYPERPLASIA AND ARE ASSOCIATED WITH INCREASED PROLIFERATIONJournal of Urology, 1999
- FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cellsJournal of Cellular Physiology, 1999
- Interleukin-6 Induces G1Arrest through Induction of p27Kip1, a Cyclin-Dependent Kinase Inhibitor, and Neuron-like Morphology in LNCaP Prostate Tumor CellsBiochemical and Biophysical Research Communications, 1999
- Expression of Fibroblast Growth Factors (FGFs) and FGF Receptors in Human ProstateJournal of Urology, 1997
- A SOLUBLE INTERLEUKIN 6 RECEPTOR ISOLATED FROM CONDITIONED MEDIUM OF HUMAN BREAST CANCER CELLS IS ENCODED BY A DIFFERENTIALLY SPLICED mRNACytokine, 1996
- Interleukin-6: A candidate mediator of human prostate cancer morbidityUrology, 1995
- Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6Science, 1994